Molecular Characterization of NF-HEV, a Nuclear Factor Preferentially Expressed in Human High Endothelial Venules, The American Journal of Pathology, vol.163, issue.1, pp.69-79, 2003. ,
DOI : 10.1016/S0002-9440(10)63631-0
IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines, Immunity, vol.23, issue.5, pp.479-490, 2005. ,
DOI : 10.1016/j.immuni.2005.09.015
Interleukin-33 and the function of innate lymphoid cells, Trends in Immunology, vol.33, issue.8, pp.389-396, 2012. ,
DOI : 10.1016/j.it.2012.04.005
Disease-associated functions of IL-33: the new kid in the IL-1 family, Nature Reviews Immunology, vol.173, issue.2, pp.103-110, 2010. ,
DOI : 10.1038/nri2692
IL-33 and IL-33 Receptors in Host Defense and Diseases, Allergology International, vol.59, issue.2, pp.143-160, 2010. ,
DOI : 10.2332/allergolint.10-RAI-0186
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis, Arthritis & Rheumatism, vol.5, issue.3, pp.738-749, 2009. ,
DOI : 10.1002/art.24305
IL-33 exacerbates antigen-induced arthritis by activating mast cells, Proceedings of the National Academy of Sciences, vol.105, issue.31, pp.10913-10918, 2008. ,
DOI : 10.1073/pnas.0801898105
Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease, Inflammatory Bowel Diseases, vol.16, issue.7, pp.1097-1107, 2010. ,
DOI : 10.1002/ibd.21175
Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis, Allergy, vol.5, issue.2, pp.183-190, 2012. ,
DOI : 10.1111/j.1398-9995.2011.02735.x
IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4, The Journal of Immunology, vol.181, issue.7, pp.4780-4790, 2008. ,
DOI : 10.4049/jimmunol.181.7.4780
IL-33 reduces the development of atherosclerosis, The Journal of Experimental Medicine, vol.209, issue.2, pp.339-346, 2008. ,
DOI : 10.1006/mthe.2001.0424
The IL-33/ST2 pathway ??? A new therapeutic target in cardiovascular disease, Pharmacology & Therapeutics, vol.131, issue.2, pp.179-186, 2011. ,
DOI : 10.1016/j.pharmthera.2011.02.005
Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection, Nature Medicine, vol.31, issue.6, pp.708-712, 2010. ,
DOI : 10.1038/nm.2156
Keratitis, Investigative Opthalmology & Visual Science, vol.51, issue.3, pp.1524-1532, 2010. ,
DOI : 10.1167/iovs.09-3983
IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes, The Journal of Immunology, vol.180, issue.4, pp.2443-2449, 2008. ,
DOI : 10.4049/jimmunol.180.4.2443
T1/St2-Deficient Mice Demonstrate the Importance of T1/St2 in Developing Primary T Helper Cell Type 2 Responses, The Journal of Experimental Medicine, vol.151, issue.6, pp.1069-1076, 2000. ,
DOI : 10.1074/jbc.271.10.5784
Organ-specific distribution of CD4+ T1/ST2+ Th2 cells in Leishmania major infection, European Journal of Immunology, vol.32, issue.9, pp.2450-2459, 2002. ,
DOI : 10.1002/1521-4141(200209)32:9<2450::AID-IMMU2450>3.0.CO;2-O
Signaling through the T1/ST2 Molecule Is Not Necessary for Th2 Differentiation but Is Important for the Regulation of Type 1 Responses in Nonhealing Leishmaniamajor Infection, Infection and Immunity, vol.71, issue.4, pp.1961-1971, 2003. ,
DOI : 10.1128/IAI.71.4.1961-1971.2003
Mononuclear Cell Recruitment, Granuloma Assembly, and Response to Treatment in Experimental Visceral Leishmaniasis: Intracellular Adhesion Molecule 1-Dependent and -Independent Regulation, Infection and Immunity, vol.68, issue.11, pp.6294-6299, 2000. ,
DOI : 10.1128/IAI.68.11.6294-6299.2000
IL-12 enhances Th1-type responses in human Leishmania donovani infections, J. Immunol, vol.154, pp.4623-4629, 1995. ,
Immunostimulatory Properties of Dendritic Cells after Leishmania donovani Infection Using an In Vitro Model of Liver Microenvironment, PLoS Neglected Tropical Diseases, vol.21, issue.6, 2010. ,
DOI : 10.1371/journal.pntd.0000703.g005
URL : https://hal.archives-ouvertes.fr/hal-00665922
Place du foie dans la leishmaniose visc??rale, Gastroent??rologie Clinique et Biologique, vol.30, issue.8-9, pp.1027-103273378, 2006. ,
DOI : 10.1016/S0399-8320(06)73378-4
Both Interleukin-4 (IL-4) and IL-4 Receptor ?? Signaling Contribute to the Development of Hepatic Granulomas with Optimal Antileishmanial Activity, Infection and Immunity, vol.71, issue.8, pp.4804-4807, 2003. ,
DOI : 10.1128/IAI.71.8.4804-4807.2003
Interleukin-33 overexpression is associated with liver fibrosis in mice and humans, Journal of Cellular and Molecular Medicine, vol.190, issue.6b, pp.1726-1739, 2010. ,
DOI : 10.1111/j.1582-4934.2009.00801.x
URL : https://hal.archives-ouvertes.fr/hal-00660257
Interleukin-33: a novel mediator with a role in distinct disease pathologies, Journal of Internal Medicine, vol.107, issue.1, pp.29-35, 2011. ,
DOI : 10.1111/j.1365-2796.2010.02316.x
IL-33: a Janus cytokine: Table 1, Annals of the Rheumatic Diseases, vol.71, issue.Suppl 2, pp.101-104, 2012. ,
DOI : 10.1136/annrheumdis-2011-200589
IL-33/ST2 axis in inflammation and immunopathology, Immunologic Research, vol.164, issue.2, pp.89-99, 2012. ,
DOI : 10.1007/s12026-012-8283-9
Interleukin-33 biology with potential insights into human diseases, Nature Reviews Rheumatology, vol.17, issue.6, pp.321-329, 2011. ,
DOI : 10.1038/nrrheum.2011.53
TRAIL but not FasL and TNF??, regulates IL-33 expression in murine hepatocytes during acute hepatitis, Hepatology, vol.31, issue.Suppl 1, pp.2353-2362, 2012. ,
DOI : 10.1002/hep.25893
NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis, European Journal of Immunology, vol.41, issue.8, pp.2341-2348, 2011. ,
DOI : 10.1002/eji.201041332
URL : https://hal.archives-ouvertes.fr/hal-00681990
Histopathological patterns of the liver involvement in visceral leishmaniasis, Revista do Instituto de Medicina Tropical de S??o Paulo, vol.29, issue.3, pp.131-136, 1987. ,
DOI : 10.1590/S0036-46651987000300003
The IL-33/ST2 pathway: therapeutic target and novel biomarker, Nature Reviews Drug Discovery, vol.348, issue.10, pp.827-840, 2008. ,
DOI : 10.1038/nrd2660
Serum Interleukin-33 Levels in Patients with Gastric Cancer, Digestive Diseases and Sciences, vol.16, issue.12, pp.3596-3601, 2011. ,
DOI : 10.1007/s10620-011-1760-5
The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ???Alarmin????, PLoS ONE, vol.106, issue.10, 2008. ,
DOI : 10.1371/journal.pone.0003331.g006
Interleukin-33, a Novel Member of the IL-1/IL-18 Cytokine Family, in Cardiology and Cardiac Surgery, The Thoracic and Cardiovascular Surgeon, vol.58, issue.08, pp.443-449, 2010. ,
DOI : 10.1055/s-0030-1250436
A role for interleukin-33 in TH2-polarized intestinal inflammation?, Mucosal Immunology, vol.157, issue.5, pp.496-502, 2011. ,
DOI : 10.1136/gut.2003.034165
T1/ST2???an IL-1 receptor-like modulator of immune responses, Cytokine & Growth Factor Reviews, vol.15, issue.2-3, pp.87-95, 2004. ,
DOI : 10.1016/j.cytogfr.2004.02.004
Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis, Acta Tropica, vol.56, issue.4, pp.315-325, 1994. ,
DOI : 10.1016/0001-706X(94)90103-1
Immunopathology of Leishmaniasis: An Update, International Journal of Immunopathology and Pharmacology, vol.189, issue.3, pp.435-445, 2007. ,
DOI : 10.1177/039463200702000302
Immune responses in kala-azar, Indian J. Med. Res, vol.123, pp.245-266, 2006. ,
Determinants of the immune response in visceral leishmaniasis: Evidence for predominance of endogenous interleukin 4 over interferon-?? production, Clinical Immunology and Immunopathology, vol.57, issue.2, pp.242-249, 1990. ,
DOI : 10.1016/0090-1229(90)90038-R
The immunopathology of experimental visceral leishmaniasis, Immunological Reviews, vol.146, issue.1, pp.239-253, 2004. ,
DOI : 10.1128/IAI.71.1.401-410.2003
Balancing immunity and pathology in visceral leishmaniasis, Immunology and Cell Biology, vol.42, issue.2, pp.138-147, 2007. ,
DOI : 10.1038/sj.icb7100011
Interleukin-12 Restores Interferon-?? Production and Cytotoxic Responses in Visceral Leishmaniasis, Journal of Infectious Diseases, vol.173, issue.6, pp.1515-1518, 1996. ,
DOI : 10.1093/infdis/173.6.1515
Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: Induction of microbicidal activity by Interferon-??, Cellular Immunology, vol.94, issue.2, pp.500-511, 1985. ,
DOI : 10.1016/0008-8749(85)90274-6
Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1., Journal of Clinical Investigation, vol.85, issue.6, pp.1914-1924, 1990. ,
DOI : 10.1172/JCI114654
Intracellular Antimicrobial Activity in the Absence of Interferon-??: Effect of Interleukin-12 in Experimental Visceral Leishmaniasis in Interferon-?? Gene-disrupted Mice, The Journal of Experimental Medicine, vol.61, issue.7, pp.1231-1239, 1997. ,
DOI : 10.1016/1074-7613(95)90163-9
T1/ST2 promotes T helper 2 cell activation and polyfunctionality in bronchopulmonary mycosis, Mucosal Immunology, vol.176, issue.2, pp.405-414, 2013. ,
DOI : 10.1073/pnas.0607863103
Invariant NKT Cells Drive Hepatic Cytokinic Microenvironment Favoring Efficient Granuloma Formation and Early Control of Leishmania donovani Infection, PLoS ONE, vol.3, issue.3, 2012. ,
DOI : 10.1371/journal.pone.0033413.s004
URL : https://hal.archives-ouvertes.fr/hal-00696897
Activity and turnover of eosinophil and neutrophil granulocytes are altered in visceral leishmaniasis, International Journal for Parasitology, vol.41, issue.3-4, pp.463-469, 2011. ,
DOI : 10.1016/j.ijpara.2010.11.005
Genetic and functional evaluation of the role of CXCR1 and CXCR2 in susceptibility to visceral leishmaniasis in north-east India, BMC Medical Genetics, vol.16, issue.9, pp.162-172, 2011. ,
DOI : 10.1038/nm.2209
IL-33 Priming Regulates Multiple Steps of the Neutrophil-Mediated Anti-Candida albicans Response by Modulating TLR and Dectin-1 Signals, The Journal of Immunology, vol.189, issue.1, pp.287-295, 2012. ,
DOI : 10.4049/jimmunol.1103564
Interleukin-33 Is hepatoprotective during liver ischemia/reperfusion in mice, Hepatology, vol.394, issue.4, pp.1468-1478, 2012. ,
DOI : 10.1002/hep.25768
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system, Journal of Clinical Investigation, vol.117, issue.6, pp.1538-1549, 2007. ,
DOI : 10.1172/JCI30634
The Th2 transcription factor c-Maf inhibits IL-12p35 gene expression in activated macrophages by targeting NF-kappaB nuclear translocation, J. Interferon Cytokine Res, vol.27, pp.799-808, 2007. ,
Regulation of interleukin 12 p40 expression through an NF-kappa B half-site., Molecular and Cellular Biology, vol.15, issue.10, pp.5258-5267, 1995. ,
DOI : 10.1128/MCB.15.10.5258
The regulation of beta-interferon gene expression, Semin. Cancer Biol, vol.1, pp.89-95, 1990. ,
Two structurally distinct kappa B sequence motifs cooperatively control LPS-induced KC gene transcription in mouse macrophages, J. Immunol, vol.155, pp.3593-3600, 1995. ,
NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene, J. Immunol, vol.153, pp.2052-2063, 1994. ,
Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1alpha, and MIP-1beta, members of the chemokine superfamily of proinflammatory cytokines, J. Immunol, vol.150, pp.4996-5012, 1993. ,
HIF-1 and NF-??B-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells, Oncogene, vol.90, issue.52, pp.7333-7345, 2007. ,
DOI : 10.1038/sj.onc.1210536
A novel form of NF-??B is induced byLeishmaniainfection: Involvement in macrophage gene expression, European Journal of Immunology, vol.169, issue.4, pp.1071-1081, 2008. ,
DOI : 10.1002/eji.200737586
Leishmania donovani activates nuclear transcription factor-??B in macrophages through reactive oxygen intermediates, Biochemical and Biophysical Research Communications, vol.322, issue.3, pp.1086-1095, 2004. ,
DOI : 10.1016/j.bbrc.2004.08.016
Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma, J. Immunol, vol.138, pp.2290-2297, 1987. ,